ARTICLE | Company News
Pfizer, Shire deal
June 20, 2016 7:00 AM UTC
Shire licensed worldwide rights to Pfizer’s PF-00547659. The anti-human mucosal addressin cell adhesion molecule 1 ( MAdCAM-1) mAb has completed Phase II testing to treat ulcerative colitis (UC) and ...